dsip peptide sleep apnea DSIP (5mg vials) - Peptide

Phase III Phase III does not offer funding from the SBIR program directly, but instead provides the contractual justification for the government to buy the capability developed in phase I and II directly without further competition because it was developed, at least in part, with government funding under the SBIR program

Philp D, Badamchian M, Scheremeta B, et al

Beijing Methycobal Clinical Trial Collaborative Group]

The Molequa peptide is in lyophilised form for laboratory scientific research (RUO)

It is derived from a partial sequence of human gastric juice protein BPC, and it carries no post-translational modifications or metal-binding requirements